Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML

Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) following chemotherapy is part of standard treatment protocol for patients with acute myeloid leukemia (AML). FUS-ERG+ AML is rare but has an extremely poor prognosis even with allo-HSCT in remission, possibly due to its a le...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Yao, Sun, Jianlin, Chen, Yarong, Liu, Botao, Li, Qinghan, Wang, Hongliang, Fang, Lu, Zhang, Hongmei, Ning, Pin, Wang, Hu, Chen, Liangding, Hu, Bin, Zhang
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6901822/
https://ncbi.nlm.nih.gov/pubmed/31850234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01358
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars